Tocilizumab is a promising treatment option for therapy resistant juvenile localized scleroderma patients

1. Foeldvari, I.
2. Anton, J.
3. Friswell, M.
4. Bica, B.
5. de Inocencio, J.
6. Aquilani, A.
7. Helmus, N.